IP Verse

Esteve Pharmaceuticals, S.a. opposition analysis

COMPANY ANALYSIS

Latest patents of Esteve Pharmaceuticals, S.a. opposed by its competitors

Patent:
EP2817000
Grant Date:
Aug 4, 2021
Title:
Oral Pharmaceutical Compositions Of Dabigatran Etexilate
Oppositions:
3

Competitors of Esteve Pharmaceuticals, S.a.

AERA A/S

GLENMARK PHARMACEUTICALS EUROPE LTD

HAMM&WITTKOPP PATENTANWALTE PARTMBB

Want to track Esteve Pharmaceuticals, S.a.?

Feel free to send us a message here and we will get back to you